Echinatin effectively protects against NLRP3 inflammasome–driven diseases by targeting HSP90-Reference-Cited by-同舟云学术

Echinatin effectively protects against NLRP3 inflammasome–driven diseases by targeting HSP90

Published:2021-01-25 Issue:2 Volume:6 Page:
ISSN:2379-3708
Container-title:JCI Insight
language:en
Short-container-title:

Author:

Xu Guang,Fu Shubin,Zhan Xiaoyan,Wang Zhilei,Zhang Ping,Shi Wei,Qin Nan,Chen Yuanyuan,Wang Chunyu,Niu Ming,Guo Yuming,Wang Jiabo,Bai Zhaofang,Xiao Xiaohe

Funder

National Science & Technology Major Project, National Natural Science Foundation of China

Beijing Nova Program

National Key R&D Program of China

Beijing-Tianjin-Hebei Collaborative Innovation Promotion Project

Youth Foundation of Chinese PLA General Hospital

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://insight.jci.org/articles/view/134601/files/pdf

Reference61 articles.

1. The Inflammasomes: Guardians of the Body

2. The Inflammasome NLRs in Immunity, Inflammation, and Associated Diseases

3. Molecular mechanisms regulating NLRP3 inflammasome activation

4. The pyroptosome: a supramolecular assembly of ASC dimers mediating inflammatory cell death via caspase-1 activation

5. Targeting the NLRP3 inflammasome in inflammatory diseases;Mangan;Nat Rev Drug Discov,2018

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Shuangdan Jiedu Decoction improved LPS-induced acute lung injury by regulating both cGAS-STING pathway and inflammasome;Journal of Ethnopharmacology;2025-01

2. Exploring the anti-inflammatory and immunomodulatory potential of licochalcone B against psoralidin-induced liver injury;Journal of Ethnopharmacology;2024-12

3. Identification of protein partners for small molecules reshapes the understanding of nonalcoholic steatohepatitis and drug discovery;Life Sciences;2024-11

4. The potential of flavonoids in hepatic fibrosis: A comprehensive review;Phytomedicine;2024-10

5. Potential Impact of Bioactive Compounds as NLRP3 Inflammasome Inhibitors: An Update;Current Pharmaceutical Biotechnology;2024-10